Details of the Drug

General Information of Drug (ID: DM6L5TR)

Drug Name
EGEN-001
Indication
Disease Entry ICD 11 Status REF
Fallopian tube cancer 2C74 Phase 2 [1]
Ovarian cancer 2C73 Phase 2 [1]
Peritoneal cancer 2C51.Z Phase 2 [1]
Cross-matching ID
TTD ID
D0OS7K
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin-12 beta (IL12B) TTGW72V IL12B_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Fallopian tube cancer
ICD Disease Classification 2C74
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Interleukin-12 beta (IL12B) DTT IL12B 1.08E-01 0.13 0.17
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01118052) EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer. U.S. National Institutes ofHealth.
2 National Cancer Institute Drug Dictionary (drug id 454593).